Clues for understanding the pathogenesis of left ventricular hypertrophy in chronic uremia

US Renal Data System. Causes of Death, Annual Data Report. Bethesda, MD: National Institutes of Diabetes and Digestive and Kidney Disease, National Institutes of Health 1995; 14: 79–90.

European Transplantation and Dialysis Association. Report on Management of Renal Failure in Europe, XXII, 1991. Nephrol Dial Transplant 1995; 10(suppl. 5): S12.

Kannel W.B. , Gordon T. , Offutt D. . Left ventricular hypertrophy by electrocardiogram: prevalence, incidence and mortality in the Framingham Study. Ann Intern Med 1969; 71: 89–105.

Messerli F.H. , Michalewicz L. . Etiology and pathophysiology of left ventricular hypertrophy. In: Koch K.M. , Stein G. eds. Pathogenetic and Therapeutic Aspects of Chronic Renal Failure. New York: M. Dekker 1997: 55–81.

Levy D. , Garrison R.J. , Savage D.D. Left ventricular mass an incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Inter Med 1989; 110: 101–7.

Ritz E. , Schwarz U. , Rambausek M. , Amann K. . Uremic cardiomyopathy. In: Koch K.M. , Stein G. eds. Pathogenetic and Therapeutic Aspects of Chronic Renal Failure. New York: M. Dekker 1997; 83–96.

Silberberg J.S. , Barre P.E. , Prichard S.S. , Sniderman A.D. . Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286–90.

Prosser D. , Parson V. . The case for a specific uremic myocardiopathy. Nephron 1975; 15: 4–7.

Raab W. , Burlington V.T. Cardiotoxic substances in the blood and heart muscle in uremia (Their nature and action). J Lab Clin Med 1944; 29: 715–34.

Huting J. , Kramer W. , Schutterle G. , Wizemann V. . Analysis of left-ventricular changes associated with chronic hemodialysis. A non-invasive follow-up study. Nephron 1988; 49: 284–90.

Parfrey P.S. , Harnett J.D. , Griffith S.M. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 1990; 55: 114–20.

Messerli F.H. . Pathophysiology of left ventricular hypertrophy. In: Cruickshank K.J.M. , Messerli F.H. eds. Left Ventricular Hypertyrophy and its Regression. London: Science Press 1992; 13–20.

Kent R.L. , Mann D.L. , Cooper G. . Signals for cardiac muscle hypertrophy in hypertension. J Cardiovasc Pharmacol 1991; 17(suppl. 2): S7–13.

Dzau V.J. . Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993; 153: 937–42.

London G.M. , Fabiani F. . Left ventricular dysfunction in end-stage renal disease. Echocardiographic insights. In: Parfrey P.S. , Harnett J.D. eds. Cardiac Dysfunction in Chronic Uremia. Basel (Switzerland): Kluwer Academic 1992; 117–37.

Levin A. , Singer J. , Thompson C.R. , Ross H. , Lewis M. . Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347–54.

Cannella G. . The circulatory system and hydrosodium volumes in chronic uremia. G Ital Cardiol 1990; 20: 438–48 (Italian).

Atuk N.O. , Bailey C.J. , Turner S. , Peach M.J. , Westervelt FB Jr. Red blood cell catechol-o-methyltransferase, plasma catecholamines and renin in renal failure. Trans ASAIO 1976; 12: 195–200.

Foley R.N. , Parfrey P.S. , Harnett J.D. , Kent G.M. , Murray D.C. , Barre P.E. . Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379–85.

Vertes V. , Cangiano J.L. , Berman L.B. , Gould A. . Hypertension in end-stage renal disease. N Engl J Med 1969; 280: 978–81.

Cannella G. , Castellani A. , Mioni G. , Usberti M. , Guerra U. , Albertini A. , Maiorca R. . Blood pressure control in end-stage renal disease in man: indirect evidence of a complex pathoge-nic mechanism besides renin and blood volume. Clin Sci Mol Med 1977; 52: 19–21.

Cannella G. . L'ipotensione arteriosa nel paziente uremico in trattamento dialitico. In: Attualità Nefrologiche e Dialitiche, Milano: Wichtig Ed 1981; 211–21.

Cheigh J.S. , Milite C. , Sullivan J.F. , Rubin A.L. , Stenzel K.H. . Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992; 19: 453–9.

Cannella G. , Paoletti E. , Delfino R. , Peloso G.C. , Molinari S. , Traverso G.B. . Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 1993; 44: 881–6.

Cruickshank J.M. , Lewis J. , Moore V. , Dood C. . Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992; 6: 85–90.

Cannella G. , LaCanna G. , Sandrini M. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients. Clin Nephrol 1990; 34: 272–8.

Matsuzaki J. , Washio M. , Nakamura S. . A clinical study of left ventricular hypertrophy and weight gain in chronic hemodialysis patients. J Jpn Soc Dial Ther 1991; 24: 1061–4 (in Japanese with English abstract).

Guyton A.C. , Coleman T.G. , Granger H.J. . Circulation: overall regulation. Am Rev Physiol 1972; 34: 13–6.

Aukland K. , Nicolaysen G. . Interstitial fluid volume: local regulatory mechanisms. Physiol Rev 1981; 61: 556–633.

Guyton A.C. , Taylor A.E. , Granger H.D. . Dynamics and control of the body fluids. In: Circulatory Physiology. Philadelphia: Saunders 1975: 330–48.

Rothe C.F. . Physiology of venous return. An unappreciated boost to the heart. Arch Intern Med 1986; 146: 977–82.

Milnor W.R. . The circulating fluid: Blood. In: Minor W.R. ed. Cardiovascular Physiology. New York: Oxford University Press 1990; 429–53.

Koomans H.A. , Geers A.B. , Boer P. , Roos J.C. , Dorhout Mees E.J. . A study on the distribution of body fluids after rapid saline expansion in normal subjects and in patients with renal insufficiency: preferential intravascular deposition in renal failure. Clin Sci 1983; 64: 153–60.

Cannella G. , Guerra U.P. , Sandrini M. Changes in partition of extracellular fluid volumes in anemic dialyzed uremic patients after partial correction of the anemia with recombinant human erythropoietin treatment. Clin Nephrol 1993; 40: 164–7.

Kooman J.P. , Wijnen J.A.G. , Draaijer P. Compliance and reactivity of the peripheral venous system in chronic intermittent hemodialysis. Kidney Int 1992; 41: 1041–8.

Brod J. , Bahlmann J. , Cachovan M. , Pretschner P. . Development of hypertension in renal disease. Clin Sci 1983; 64: 141–52.

London G.M. , Guerin A.P. , Marchais S.J. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600–8.

London G.M. , Drueke T.B. . Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997; 51: 1678–95.

Saba P.S. , Roman M.J. , Pini R. , Spitzer M. , Ganau A. , Devereux R.B. . Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22: 1873–80.

Marchais S.J. , Guerin A.P. , Pannier B.M. , Levy B.I. , Safar M.E. , London G.M. . Wave reflections and cardiac hypertrophy in chronic uremia: influence of body size. Hypertension 1993; 22: 876–83.

Bergstrom J. . Catecholamines and control of blood pressure in hemodialysis and hemofiltration. Kidney Int 1988; 24(suppl. 25): S110.

Cannella G. , Picotti G.B. , Movilli E. Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. Nephron 1981; 27: 285–91.

Bernardi D. , Bernini L. , Cini G. , Ghione S. , Bonechi I. . Asymmetric septal hypertrophy and sympathetic overactivity in normotensive hemodialyzed patients. Am Heart J 1985; 109: 539–45.

Amann K. , Tornig J. , Flechtenmacher C. , Nabokov A. , Mall G. , Ritz E. . Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH. Nephrol Dial Transplant 1995; 10: 2043–8.

Ma K.W. , Greene E.L. , Raij L. . Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992; 19: 505–13.

Cannella G. , Paoletti E. , Delfino R. , Peloso G.C. , Rolla D. , Molinari S. . Prolonged therapy with ACE-inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis 1997; 30: 659–64.